Back
Cullen/Frost Bankers Vs. Spyre Therapeutics Industry Stock Comparison
Sell
36
CFR
Cullen/Frost Bankers
Last Price:
111.18
Seasonality Move:
-1.78%
Buy
59
SYRE
Spyre Therapeutics
Last Price:
28.46
Seasonality Move:
-2.85%
Sell
36
Cullen/Frost Bankers (CFR)
is a Sell
Is Cullen/Frost Bankers a Buy, Sell or Hold?
- The current Cullen/Frost Bankers [CFR] share price is $111.73. The Score for CFR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- CFR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $29.04. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CFR Stock Price Chart
What is Cullen/Frost Bankers's stock price today?
-
The Cullen/Frost Bankers share price today is $111.73
The current trend is moderately bullish and CFR is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $29.04
The current trend is moderately bearish and SYRE is experiencing slight buying pressure.
CFR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.81 | Buy |
| Relative Strength Index (14 RSI): | 53.24 | Buy |
| Chaikin Money Flow: | 43643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (108.25 - 113.13) | Buy |
| Bollinger Bands (100): | (100.37 - 112.37) | Buy |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 53.02 | Buy |
| Chaikin Money Flow: | 71063 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.98 - 29.52) | Buy |
| Bollinger Bands (100): | (25.44 - 33.84) | Sell |
CFR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.51 | Sell |
| 20-day SMA: | 110.6 | Buy |
| 50-day SMA: | 110.84 | Buy |
| 200-day SMA: | 106.96 | Buy |
| 8-day EMA: | 111.79 | Sell |
| 20-day EMA: | 110.94 | Buy |
| 50-day EMA: | 109.55 | Buy |
| 200-day EMA: | 107 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.1 | Sell |
| 20-day SMA: | 28.66 | Buy |
| 50-day SMA: | 27.88 | Buy |
| 200-day SMA: | 29.31 | Sell |
| 8-day EMA: | 28.88 | Buy |
| 20-day EMA: | 28.56 | Buy |
| 50-day EMA: | 28.37 | Buy |
| 200-day EMA: | 27.36 | Buy |
Cullen/Frost Bankers Earnings Growth & CFR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.93 per share, and a decrease next year of $0.09 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
Cullen/Frost Bankers Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||